Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025
06:45am, Monday, 01'st Dec 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025.
Capital Counsel LLC NY Increases Stock Position in Merck & Co., Inc. $MRK
04:16am, Monday, 01'st Dec 2025
Capital Counsel LLC NY lifted its position in shares of Merck and Co., Inc. (NYSE: MRK) by 1.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Ex
BLI Banque de Luxembourg Investments Takes Position in Merck & Co., Inc. $MRK
03:30am, Monday, 01'st Dec 2025
BLI Banque de Luxembourg Investments acquired a new stake in shares of Merck and Co., Inc. (NYSE: MRK) during the second quarter, according to its most recent Form 13F filing with the Securities and E
These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders
04:45am, Sunday, 30'th Nov 2025
Merck is a high-yield drug stock with a well-supported dividend payment. Enbridge is a boring energy stock with a hefty yield.
Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%?
06:33pm, Saturday, 29'th Nov 2025
One of Merck's key assets has just scored a significant phase 2 win, boosting investor confidence. This adds to other recent developments that could help the company overcome its challenges.
Merck: Excellence Across The Board
10:00am, Friday, 28'th Nov 2025
Merck (MRK) demonstrates excellence across the board through its resilient revenue mix, expanding profitability, and stellar capital allocation. MRK's innovation, highlighted by Keytruda's dominance a
Clarkston Capital Partners LLC Acquires 2,143 Shares of Merck & Co., Inc. $MRK
04:18am, Friday, 28'th Nov 2025
Clarkston Capital Partners LLC raised its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 11.8% in the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned
AstraZeneca or Merck: Which Oncology Giant Has the Edge?
10:46am, Thursday, 27'th Nov 2025
AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
10:01am, Thursday, 27'th Nov 2025
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Baltimore Washington Financial Advisors Inc. Increases Stake in Merck & Co., Inc. $MRK
03:52am, Thursday, 27'th Nov 2025
Baltimore Washington Financial Advisors Inc. grew its position in Merck and Co., Inc. (NYSE: MRK) by 22.4% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owne
Market Today: Stocks Rally, Tesla Robotaxi and Nvidia Scrutiny
05:35pm, Wednesday, 26'th Nov 2025
Stock News Campbell's exec ousted after viral recording: Campbell Soup (CPB) said it terminated IT VP Martin Bally after an internal review concluded he was the
Will Soft Gardasil Demand Continue to Dampen Merck's Top Line?
10:51am, Wednesday, 26'th Nov 2025
MRK faces steep Gardasil declines as China and Japan demand soften, putting pressure on its vaccine portfolio.
Why Is Merck Stock Surging?
08:25am, Wednesday, 26'th Nov 2025
Merck (MRK)'s stock surged by 41% over the past six months, driven not significantly by revenue, but rather by increased profits and heightened investor confidence. Following crucial Q3 earnings excee
First Look: Campbell Soup fallout, Alphabet AI strength, Nvidia rebuttal
07:39am, Wednesday, 26'th Nov 2025
Stock News Campbell puts exec on leave: Campbell's Co. (CPB) sidelined a senior IT executive after a lawsuit and leaked audio alleged he disparaged customers an
Merck to Participate in the Citi 2025 Global Healthcare Conference
07:15am, Wednesday, 26'th Nov 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the Citi 2025 Global Healthcare Conference.
